ACTR087
Showing 1 - 3 of 3
Multiple Myeloma, Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in United States (ACTR087, SEA-BCMA)
Terminated
- Multiple Myeloma
- +2 more
- ACTR087
- SEA-BCMA
-
Phoenix, Arizona
- +6 more
Mar 27, 2020
Lymphoma Trial in United States (ACTR087, rituximab)
Completed
- Lymphoma
- ACTR087
- rituximab
-
Gilbert, Arizona
- +6 more
Mar 27, 2020
Solid Tumor, HER-2 Protein Overexpression Trial in United States (ACTR T Cell Product, Trastuzumab)
Terminated
- Solid Tumor
- HER-2 Protein Overexpression
- ACTR T Cell Product
- Trastuzumab
-
New Haven, Connecticut
- +5 more
Mar 27, 2020